Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTELLIGENT BIO SOLUTIONS INC.GBS · Entity 8088 | Director | March 02, 2021 | March 04, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTELLIGENT BIO SOLUTIONS INC.
Report date March 02, 2021 · Filed March 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| GBS Common StockSEC Table I · non-derivative | Direct | 36.63 |
Reported balance
After 2021-03-02 transaction · row 1
1 source rowRow 1 · 2021-03-02 · Purchase · Acquired 36.63 · Balance 36.63 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2021 Filed Mar 4, 2021 00:24 UTC | INTELLIGENT BIO SOLUTIONS INC. GBS · Entity 8088 | PurchaseGBS Common Stock | 36.63 | $8.09 | $296.34 |
DisclosureSEC source: 0001493152-21-005316 · ownership.xml · nonDerivative · entry 1 Gavrilenko Victoria · CIK 0001830108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36.63 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.